Open original FDA record ↗Recall record
- FDA identifier
- Z-1452-04
- Company in FDA record
- Abbott Laboratories HPD/ADD/GPRD
- FDA classification date
- Sep 14, 2004
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Changes in the ARCHITECT B12 Reagent lots may adversely affect the shape of the calibration curve, over time. These changes may produce controls out of range low and similar decreases in patient sample values prior to current expiration of the reagents.
Source facts
- Action
- Abbott affiliates in Canada, Germany, Singapore, Hong Kong, Australia, New Zealand and Japan were e-mailed copies of the recall letter on 8/19/04 for translation where needed and dissemination to their accounts receiving the suspect lots. The end users were advised of the potential for changes in the reagents over time that affect the shape of the calibration curve, producing controls out of range low and similar decreases in patient sample values. The accounts were instructed to manually update the expiration dates for the reagent lots according to the chart given in the recall letter for any of the affected lots remaining in inventory. The expiration date reported by the Architect instrument must also be manually updated.
- Initiated
- 2004-08-19
- Root cause
- Other
- Terminated
- 2005-07-29
- Distribution
- Canada, Germany, Singapore, Hong Kong, Australia, New Zealand and Japan.
- Recall number
- Z-1452-04
- Recall status
- Terminated
- CDRH record ID
- 34759
- FDA classified
- 2004-09-14
- Recall event number
- 29911